That's an incredily heavy question Herr Buffett, especially considering this is all hypothetical and highly speculative.  But I will give it a shot none the less...and I find it helps to start with facts.

Resverlogix is a publicly traded company that is listed on the TSX, in the US its shares are not listed so they trade over the counter.

Zenith, I don't pay any real attention to Zenith because I don't have any skin in the game...but I know it is not a publicly traded company.  

HL is publicly traded, but only in China. And thanks to Koo's dogged research we know that HL is looking at a bond issue to raise cash....to what end though we don't know.

Zenith and Resverlogix are development stage companies with basically no revenue.  HL, according to the Beacon report is the world's largest supplier of Heparin sodium (if memory serves), which is why they're called  Hepalink I assume...Hepalink, Heparin

Now onto pure speculation....

I'm gonna cut to the chase because I could be up all night going down this rabbitt hole....this is what I'm speculating.

Resverlogix has an IPO on the Naz....then HL takes over, a M&A deal is struck and the company is rebranded, PharmaGlobe....pick a name, I'm no branding expert. 

I'm not saying it will happen, consider it my version of a CVR deal :-)

What would such a deal mean for RVX shareholders? I'll leave others to speculate on that....and I purposefully left Zenith out because I don't know enough about it, besides it only further complicates what is only a hypothetical scenario anyway.